Quick Answer
10x Genomics, Inc. reported Long-Term Debt of $0.00 for fiscal year 2020.
10x Genomics, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2020 | $0.00 | -100.0% |
| 2019 | $19.84M | -22.2% |
| 2018 | $25.49M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $0.00 | -100.0% | — |
| June 30, 2020 | $0.00 | — | — |
| March 31, 2020 | $0.00 | — | -100.0% |
| December 31, 2019 | $19.84M | -22.2% | -11.1% |
| September 30, 2019 | $22.31M | — | -12.5% |
| December 31, 2018 | $25.49M | — | — |
- 10x Genomics, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2018–2020 period, 10x Genomics, Inc.’s long-term debt has declined by 100.0% (from $25.49 million to $0.00).
- The most recent figure is from 10x Genomics, Inc.’s fiscal year 2020 report (Form 10-K), filed with the SEC on February 26, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: